Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
Source check: Source checked. Not independent scientific confirmation.
Finding: A LightGBM model using demographic, spirometry, treatment, claims, weather, pollution and respiratory-virus features predicted daily COPD exacerbation risk from 590 KOCOSS patients (AUC 0.935; F1 0.653). The paper also reports external evaluation in 2,151 KNHANES participants; this is a retrospective prediction result, not prospective clinical benefit. The result remains bounded to the reported datasets and assays.
Technology: LightGBM daily exacerbation-risk model
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- LightGBM used clinical, claims, weather, air-pollution and respiratory-virus inputs to predict daily COPD exacerbation; separate KNHANES evaluation was weaker than development results.
- Test and result
- A LightGBM model using demographic, spirometry, treatment, claims, weather, pollution and respiratory-virus features predicted daily COPD exacerbation risk from 590 KOCOSS patients (AUC 0.935; F1 0.653). The paper also reports external evaluation in 2,151 KNHANES participants; this is a retrospective prediction result, not prospective clinical benefit.
- Limitation / still unknown
- The source-checked evidence does not establish broader external validity or prospective benefit. Affiliation was not available in the retrieved trusted primary metadata.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/37907619 · https://pmc.ncbi.nlm.nih.gov/articles/PMC10618439/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.